Publication | Open Access

Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1

Polo-box DomainSignaling PathwayMedicineReceptor Tyrosine KinaseAnti-cancer AgentPharmacologyCell BiologyCell SignalingNovel TherapyDrug DiscoveryPolo-like Kinase 1Cyclic Peptomer Inhibitors